Sign In
  • Africa
  • Trump
  • African
  • Guardian
  • Mail
  • South
logo
  • Home
  • Ghana
  • Africa
  • World
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Health
  • Crime
  • Lifestyle
Reading: FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
Share
African News HeraldAfrican News Herald
Font ResizerAa
Search
  • Home
  • Ghana
  • Africa
  • World
  • Politics
  • Business
  • Technology
  • Sports
  • Entertainment
  • Health
  • Crime
  • Lifestyle
Follow US
© 2024 africanewsherald.com – All Rights Reserved.
African News Herald > Blog > Business > FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
Business

FDA approves first medication for obstructive sleep apnea — which also promotes weight loss

ANH Team
Last updated: December 26, 2024 12:44 am
ANH Team
Share
SHARE

The US Food and Drug Administration (FDA) recently approved the first medication for obstructive sleep apnea, a condition that affects millions of people, especially those who are overweight or obese. The medication, called Zepbound (tirzepatide), is manufactured by Eli Lilly and is intended to be used in conjunction with a reduced-calorie diet and increased physical activity.

Sleep apnea occurs when the upper airway becomes blocked during sleep, leading to pauses in breathing. Zepbound works by activating receptors of hormones secreted from the intestine to reduce appetite and food intake, similar to other medications like Ozempic and Wegovy. Studies have shown that by helping to reduce body weight, Zepbound can also improve symptoms of obstructive sleep apnea.

In a 52-week study, participants treated with Zepbound experienced a significant reduction in events of apnea or hypopnea, with many achieving remission of symptoms. However, the medication does come with potential side effects such as nausea, diarrhea, and stomach discomfort. It is also important to note that Zepbound may cause thyroid C-cell tumors in rats, although it is unknown if this risk extends to humans.

Dr. Wendy Troxel, a sleep expert, praised the FDA’s approval of Zepbound as a promising advancement for those suffering from sleep apnea. She noted that while positive airway pressure (PAP) therapy is effective, many patients struggle with adherence. Zepbound offers an alternative treatment option, particularly for obese individuals with moderate to severe sleep apnea.

Dr. William Lu, medical director of Dreem Health, highlighted the significance of Zepbound in addressing the interconnected issues of obesity and sleep apnea. He emphasized the importance of getting tested for sleep apnea and making lifestyle changes to improve overall health.

See also  How will FDA change under Trump? 3 issues to watch in 2025

In conclusion, the approval of Zepbound by the FDA represents a significant milestone in the treatment of obstructive sleep apnea. This new medication offers hope for those struggling with the condition and provides a valuable treatment option for improving sleep quality and overall health.

Subscribe to Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

I have read and agree to the terms & conditions
TAGGED:apneaApprovesFDAlossmedicationobstructivepromotessleepweight
Share This Article
Twitter Email Copy Link Print
Previous Article ‘Vengeance Most Fowl’: Wallace and Gromit return with comic warning about AI dystopia
Next Article Burglary crew uses chains, stolen cars to steal ATMs, cops say
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Editor's Pick

Best Phone 2024: Top 10 Mobile Phones Today

Need a new phone? The constant influx of new handsets can make it challenging to keep track of what's worth…

November 12, 2024 3 Min Read
14 best trading platforms in Nigeria 

Avatrade is regulated by the Central Bank of Ireland, ASIC in Australia,…

20 Min Read
The fall of Ghana’s NPP and the resurgence of the NDC in the 2024

The 2024 general elections in Ghana marked a seismic shift in the…

8 Min Read

Lifestyle

Recipe for resilience: What perfect pasta teaches us about medical scheme governance

Governance and cooking may seem like two completely different worlds,…

June 30, 2025

WATCH: The Makhathinis hit the mark! Scoop and Zulu on the Red carpet

The premiere of F1: The Movie…

June 29, 2025

NAG magazine unveils winter edition with Doom: The Dark Ages

The latest issue of NAG magazine…

June 29, 2025

Recipe of the day: Winter’s day warm Shakshuka

Are you looking to warm up…

June 28, 2025

Lego’s Speed Champions F1, an adrenaline build

Speed Champions is a thrilling experience…

June 28, 2025

You Might Also Like

Business

Jerome Powell accused of lying to Congress over $2.5B ‘Palace of Versailles’ HQ revamp

Federal Reserve Chair Jerome Powell is under scrutiny for allegedly lying to Congress about the extravagant $2.5 billion renovation of…

3 Min Read
Business

Tanzania, Kenya, and South Africa dominate 2025 World Travel Awards in Dar es Salaam

African nations shone brightly at the 2025 World Travel Awards (WTA) Africa & Indian Ocean Gala Ceremony, which took place…

3 Min Read
Health

Addiction medication access lags for Black, Hispanic patients

Racial Disparities in Access to Opioid Addiction Medications A recent study has shed light on the concerning racial disparities in…

3 Min Read
Business

Nvidia insiders sold over $1 billion in stock amid market surge, FT reports

Nvidia insiders have reportedly sold more than $1 billion worth of company stock in the past year, with a significant…

2 Min Read
logo logo
Facebook Twitter Youtube

About US

Stay informed with the latest news from Africa and around the world. Covering global politics, sports, and technology, our site delivers in-depth analysis, breaking news, and exclusive insights to keep you connected with the stories that matter most.

Top Categories
  • Africa
  • Business
  • Entertainment
  • Sports
Usefull Links
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2024 africanewsherald.com –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?